Adult mammalian hearts typically have little capacity to regenerate after injuries such as myocardial infarction. In contrast, neonatal mice during the first week of life possess an incredible ability to regenerate their hearts, though this capacity is lost shortly after birth. The physiological triggers mediating this transition remains poorly understood. In this study, we demonstrate that sympathetic nerve activity promotes cardiomyocyte cell-cycle arrest and binucleation. In mice hearts lacking sympathetic nerve inputs, we observe increased mononucleated cardiomyocyte numbers and elevated cardiomyocyte proliferation. Additionally, increased cardiomyocyte mononucleation and proliferation are observed in mice with genetic and pharmacological inhibition of β-adrenergic receptors (βARs), which mediate sympathetic nerve signaling. Using in vitro cultures of neonatal cardiomyocytes, we demonstrate that activation of β-adrenergic receptors results in decreased cardiomyocyte proliferation that is mediated through cyclic AMP-dependent protein kinase (PKA) signaling. Taken together, these results suggest that sympathetic nerve activity may play a role in limiting the ability of mammalian hearts to regenerate by restricting cardiomyocyte proliferation and promoting cytokinesis failure leading to multinucleation.
INTRODUCTION
Lower vertebrates such as adult newts and zebrafish, and even mammals at embryonic and neonatal stages possess remarkable abilities to robustly regenerate their hearts. 1 Previous studies have demonstrated vigorous cardiomyocyte proliferation in injured newt hearts, [2] [3] [4] particularly when the hearts were injured at the base of the ventricles. 5 Lizard cardiomyocytes demonstrate robust proliferation and regeneration after injury. 6 Adult zebrafish are capable of complete heart regeneration after surgical removal of up to 20% of the ventricle as well as in cryoinjury and genetic cell-ablation models. 7, 8 Recently, an amazing capacity for complete cardiac regeneration has been observed in neonatal mice 9 and even humans. 10 However, this capacity is lost shortly after birth in one-week old mice 9 , consistent with the inability of adult humans to regenerate their hearts after myocardial infarction. 1, 9, [11] [12] [13] In line with this, most mammalian organs and appendages including brain, skin, and limbs have reduced regenerative potential during postnatal growth. 9, [14] [15] [16] [17] [18] Understanding the evolutionary and developmental mechanisms regulating regenerative potential could lead to new therapeutic strategies in regenerative medicine; however, our current understanding of these mechanisms is limited.
In adult zebrafish and neonatal mice, heart regeneration occurs primarily through proliferation of pre-existing cardiomyocytes rather than expansion and differentiation of stem cell populations. 1, 11, 19, 20 Unfortunately, mammalian cardiomyocytes withdraw from the cellcycle shortly after birth. 1 In newborn mice, cardiomyocytes undergo a final round of DNA duplication and division during the first weeks of life. 12 However, due to cytokinesis failure, approximately 90 percent of murine cardiomyocytes binucleate rather than completely divide into individual cells. The increase in heart size from neonatal to adult stages is predominantly due to cardiac hypertrophy with cardiomyocyte renewal rates at less than one percent per year. 1 In contrast, greater than 95 percent of adult zebrafish and newt cardiomyocytes are mononucleated and retain proliferative activity. 21, 22 Because of this, it is hypothesized that loss of mammalian cardiomyocyte proliferative activity during neonatal stages restricts cardiac regenerative potential in adulthood.
Significant progress has been made in identifying intrinsic regulators of cardiomyocyte proliferation including cyclins, microRNAs, transcription factors and cofactors YAP, [23] [24] [25] [26] [27] [28] TBX20, [29] [30] [31] [32] [33] [34] and MEIS1. 35 A significant gap in our understanding is in understanding what upstream extrinsic triggers drive permanent mammalian cardiomyocyte cell-cycle arrest.
Exposure to postnatal oxygen levels and accompanying increases in oxidative stress has been identified as a driver of cardiomyocyte cell-cycle arrest. 36 However, only a marginal increase in mononucleated cardiomyocytes of less than five percent was observed in animals chemically or genetically manipulated to reduce oxidative stress, suggesting that other pathways are likely to also regulate this process.
In this study, we analyze the effects of the sympathetic nervous system in cardiomyocyte cell-cycle control. Sympathetic nerves regulate the rate and force of cardiomyocyte contractility through activation of β-adrenergic receptors (βARs) expressed in the innervated heart. 37 While sympathetic nerve innervation is observed in murine hearts by embryonic stage 13.5 (E13.5), 38 studies in rats suggest that sympathetic nerve activation does not occur until after birth. 39 As this coincides with the timing of cardiomyocyte binucleation and cell-cycle arrest, 40 we hypothesized that sympathetic nerve activity could be an extrinsic factor mediating this transition. 
Cryosectioning
Hearts were harvested and blood manually removed through gentle pumping. Extraneous tissues were excised leaving only atria and ventricles intact. Hearts were then briefly soaked in chilled 30% sucrose in PBS and then mounted in cryomolds (TissueTek) containing O.C.T.
compound (TissueTek) on ice, allowed to equilibrate for 10 minutes, and then flash-frozen in liquid nitrogen. Tissue blocks were then sectioned to 5-mm thickness using a Leica CM3050 S cryostat, allowed to dry, and then stored at -80°C. Prior to staining, sections were fixed for 10 to 15 min in 3.7% formaldehyde and washed with PBS. After fixation, sections were washed three times in PBS prior to antibody staining.
Neonatal cardiomyocyte isolation and culture
Our culture protocol for neonatal ventricular cardiomyocytes was adapted from one previously established for adult zebrafish cardiomyocyte culture. 44 Ventricles were isolated from P1 to P3 neonatal mice and rinsed in perfusion buffer (same as used for cardiomyocyte dissociation) Each heart was then cut into four small pieces to facilitate digestion and transferred into 2-mL Eppendorf tubes (at most two hearts per tube) containing 1 mL digestion buffer (2 mg/mL collagenase II dissolved in perfusion buffer). Tubes were incubated with rocking agitation at 37°C incubator for 30 minutes. Heart pieces were allowed to settle, supernatant discarded, and fresh pre-warmed digestion buffer replaced. Samples were then incubated for 15 minutes at 37°C, supernatants again discarded, and pre-warmed digestion buffer replaced. Next, samples were incubated for 15 minutes and this time, the supernatant was collected and 1/10 th volume FBS was added to neutralize the digestion. Fresh pre-warmed digestion buffer was added to the undigested heart pieces and subsequent collections were taken every 10 minutes until complete digestion of the heart was observed. Pooled collections were then centrifuged at 200 x g for five minutes at 4°C. Pelleted cells were then washed in perfusion buffer containing increasing concentrations of CaCl 2 (12.5 µm, 62 µm, 112 µm, 212 µm , 500 µm, 1000 µm). Finally, cells were resuspended in culture media consisting of high glucose DMEM (UCSF cell culture facility) with 20% FBS (UCSF cell culture facility), 5% horse serum (Corning Cellgro), and primocin (InvivoGen). Cells were then pre-plated in a 6-well culture plate for 1 hour at 37°C with 5% CO 2 to enrich for cardiomyocytes prior to plating on 0.2% gelatin-coated 96-well plates (Corning Life Sciences). In 100 µL volumes, 20,000 to 25,000 cells were plated per each well of a 96-well plate. Culture media was replaced at least once every two days as needed.
Chemical treatments
Chemicals were added to cultured cardiomyocytes 24 hours after initial plating at the following concentrations: 5 µM 5-ethynyl-2'-deoxyuridine (SCBT, sc-284628); 10 µM norepinephrine (Sigma, A0937); 10 µM isoproterenol (Sigma, I6504); 100 µM phenylephrine (Sigma, P6126); 10 µM propranolol; 1 µM forskolin (gift from Roshanak Irannejad) and 1 µM KT5720 (EMD-Millipore, 80052-786). After incubation in the compounds for 48 hours, cardiomyocytes were washed briefly with PBS, fixed in 3.7% formaldehyde for 10 to 15 minutes, and washed again with PBS. Samples were washed three times with PBST, incubated with fluorophore-conjugated secondary antibodies for at least 2 hours at room temperature, washed three times with PBST, and then stained with DAPI.
EdU detection

Imaging and image processing
Tissue sections and cultured cells were imaged on an inverted epifluorescent microscope (Nikon Eclipse Ti) or an upright confocal set-up (Leica SPE). Images were processed in FIJI (https://fiji.sc/) or Photoshop (Adobe) and linear adjustments were made to brightness and contrast settings.
Image quantification
Images were quantified manually with either FIJI using the Cell Counter plug-in or
Photoshop. For nucleation analysis, approximately 200 unambiguous cardiomyocytes were analyzed per sample. For tissue sections, Ki67-(+) cardiomyocyte nuclei were quantified in three independent sections per sample and averaged. For cultured cardiomyocytes, an average of 750 cardiomyocyte nuclei were analyzed per condition.
Statistics
P-values were obtained using the Student's t Test when comparing two independent samples. For multiple comparisons, one-way analysis of variance (ANOVA) was performed using Prism 7 (GraphPad).
RESULTS
Sympathetic nerve ablation increases cardiomyocyte mononucleation and proliferation
To assess the role of sympathetic nerves in the regulation of cardiomyocyte proliferation and nucleation, we utilized a previously established genetic approach to ablate sympathetic nerve innervation. 38 As the survival of sympathetic neurons requires expression of the nerve growth factor receptor Tropomyosin receptor kinase A (TrkA), 45 we crossed mice harboring a conditional Fig. 1A-B) . From these dissociated samples, we observed intact cardiomyocytes containing a single nucleus (mononucleated), two nuclei (binucleated), and greater than or equal to three nuclei (polynucleated). Quantification of cardiomyocyte nucleation state under these conditions revealed that TH-Cre; TrkA f/f mice possessed elevated mononucleated cardiomyocyte numbers (23.0%, n = 3) compared to that observed in TrkA f/f sibling controls (13.8%, n = 3).
To determine if increased mononucleated cardiomyocytes in TH-Cre; TrkA f/f mice correlated with increased cardiomyocyte proliferation, we analyzed 5 µm-thick cyrosections from mutant and control hearts (Fig. 1C-D) . To unambiguously identify cardiomyocyte nuclei,
we stained tissue sections with antibodies against pericentriolar material 1 (PCM-1), which adopts a perinuclear localization specifically in cardiomyocytes. 46 
β-adrenergic receptor inhibition increases cardiomyocyte mononucleation and proliferation
Through the release of potent neurotransmitters such as norepinephrine (NE), sympathetic neurons activate β-adrenergic receptors (βARs) expressed in innervated tissues. 47 To test if βAR-activation affects cardiomyocyte nucleation and proliferation during perinatal development, we injected mice once-a-day from P0 to P14 with propranolol (40 µg per g bodyweight), a non-selective β-blocker. 48 We harvested hearts from propranolol-injected mice at P14 and dissociated cardiomyocytes into isolated single cells ( Fig. 2A-B) . Analysis and quantification of cardiomyocyte nucleation revealed that βAR inhibition during the first two weeks after birth increased the percentage of mononucleated cardiomyocytes (22.1%, n = 6) compared to that observed in saline-injected controls (11.6%, n = 7). Additionally, when we analyzed the hearts of one-year-old mutant mice lacking function of all three βAR isoforms (βAR TKO) we again observed an increased percentage of mononucleated cardiomyocytes in these mutants (17.6%, n = 3) compared to that observed in age-matched wild-type mice (5.19%, n = 3) (Fig. 2C-D) .
To assess if elevated mononucleated cardiomyocytes in animals with reduced βAR function correlated to increased cardiomyocyte proliferation, we harvested propranolol-and saline-injected hearts at P14, generated 5 µm-thick cryosections, and stained these samples with antibodies against PCM-1 and Ki67. Quantification of PCM-1-(+); Ki67-(+) cells indicated that inhibition of βARs during the perinatal window with daily propranolol injection increased the percentage of proliferative cardiomyocytes (1.38%, n = 3) compared to saline-injected controls (0.41%, n = 3). These results suggest that inhibition of βARs specifically during first two weeks after birth results in increased numbers of mononucleated cardiomyocytes with increased proliferative activity in vivo, corroborating the phenotypes observed in hearts lacking sympathetic nerve innervation.
Activation of βARs suppress cardiomyocyte proliferation in vitro
Though our in vivo experiments suggested a role for sympathetic nerve activity in cardiomyocyte cell-cycle control, it is possible that these effects are mediated through indirect mechanisms as the heart consists of other cell types including fibroblasts and endothelial cells. 49 To more directly test the effects of bAR signaling on cardiomyocytes themselves, we isolated and cultured cardiomyocytes from P1-P3 neonatal mice. By analyzing incorporation of the thymidine nucleoside analog 5-ethynyl-2'-deoxyuridine (EdU) as a marker for proliferative activity combined with antibody staining of PCM-1 and the cardiomyocyte-specific marker cardiac troponin T (cTnT), we characterized the basal proliferation rates of cardiomyocytes in our in vitro culture system (Fig. 3A) . From six independent cardiomyocyte culture experiments, we determined that on average ~1.5% of cardiomyocytes are EdU-(+) after 2 days of incubation with EdU; however, we also noticed that baseline proliferation among independent experiments ranged greatly (0.76% to 2.26%) (Fig. 3B) . To take this variation into account, we normalized all experimental conditions against the control baseline proliferation for that specific experiment.
We tested a panel of chemical modulators of both β-and α-adrenergic receptors in our in vitro proliferation assay (Fig. 3C-D) . Activation of both β-and α-adrenergic receptors with norepinephrine (NE) resulted in strong suppression of cardiomyocyte proliferation. βAR-specific activation with isoproterenol (ISO) also caused significant inhibition of cardiomyocyte cell-cycle activity, supporting the role of βARs in cardiomyocyte proliferative control.
Treatment with phenylephrine (PE), an α-adrenergic receptor (αAR)-specific agonist, also resulted in mild suppression of cardiomyocyte cell-cycle activity possibly suggesting at least some role for αARs in controlling cardiomyocyte proliferation. Importantly, treatment with the βAR inhibitor propranolol in combination with NE prevented NE-dependent inhibition of cardiomyocyte proliferation, confirming that NE exerts its effects on cardiomyocyte proliferation through βARs. In combination, our in vitro results are in agreement with our in vivo findings illustrating a role for sympathetic nerve activity through regulation of βARs in cardiomyocyte cell-cycle control.
βARs function through PKA to control cardiomyocyte cell-cycle activity
Canonical βAR activation is believed to increase intracellular cyclic AMP levels leading to activation of cyclic AMP-dependent protein kinase (PKA) to mediate downstream cellular effects. 50 We hypothesized that βAR-dependent regulation of cardiomyocyte proliferation could also depend on PKA activity. Using our in vitro proliferation assay, we treated cultured cardiomyocytes with NE alone and in combination with chemical modulators of PKA signaling, forskolin and KT5720 (Fig. 4A-B) . Treatment of cardiomyocytes with the PKA activator forskolin phenocopied the effects of NE treatment leading to robust inhibition of cardiomyocyte proliferation. While addition of the PKA inhibitor KT5720 did not have a significant effect on baseline cardiomyocyte proliferation, treatment of both KT5720 and NE simultaneously reduced the efficacy of NE to inhibit cardiomyocyte proliferation. Additionally, treatment of NE with forskolin did not lead to enhanced cell-cycle suppression beyond that observed with NE treatment alone, suggesting that NE may function predominantly through a PKA-dependent mechanism to regulate cardiomyocyte cell-cycle activity.
DISCUSSION
Cumulatively, our results support a model where sympathetic nerve activity during neonatal development promotes cardiomyocyte cell-cycle arrest and binucleation (Fig. 5) . Using a genetic system to ablate sympathetic neurons, we demonstrate that mice lacking sympathetic innervation possess elevated mononucleated cardiomyocyte populations with increased proliferative activity two weeks after birth. Furthermore, by examining mutant mice lacking function of all three βAR isoforms, we observed a similar increase in cardiomyocyte mononucleation that persisted until at least one year of age, suggesting that sympathetic nerves may act through βARs to mediate cardiomyocyte cell-cycle control in vivo. Pharmacological inhibition of βARs with propranolol specifically within the first two weeks after birth phenocopied the increase in cardiomyocyte mononucleation and proliferation observed in animals depleted of sympathetic neurons. Therefore, despite cardiac sympathetic nerve innervation at E13.5, 38 it is likely that nerve-dependent activation of βARs during the first twoweeks after birth is responsible for limiting cardiomyocyte proliferative capacity. Our in vitro cardiomyocyte culture experiments corrborate our in vivo findings demonstrating that activation of βARs inhibits neonatal cardiomyocyte proliferation through a PKA-dependent mechanism.
Activation of βARs is known to regulate the rate and force of cardiomyocyte contractility. 37 During adult zebrafish heart regeneration, cardiomyocyte dedifferentiation and sarcomeric disassembly have been observed suggesting that inactivation of the contractile apparatus may be necessary for cell division. 51 It is possible that the increase in cardiac sympathetic tone during the first weeks after birth may stabilize the contractile machinery preventing cell proliferation. However while treatment of neonatal cardiomyocytes with the αAR-specific agonist phenylephrine dramatically increased the rate of cardiomyocyte contraction in vitro (data not shown), only mild reduction of cardiomyocyte proliferation was observed in our assays (Fig 3C-D) . Therefore, βARs could potentially regulate cardiomyocyte cell-cycle independently from contractility.
It was previously reported that treatment of neonatal rats with propranolol inhibited cardiomyocyte proliferation through the P70 S6K pathway. 52 . It is important to note that while we focused on the effect of βAR inhibition over the course of two-weeks, Tseng et al focused on the effects of βAR inhibition over the time scale of minutes to hours. Additionally, to increase the accuracy of our quantifications, we stained our tissues and cells with PCM-1, a recently validated marker for cardiomyocyte nuclei. 46 Nevertheless, it remains possible that inhibiting βAR signaling could have differing effects on cardiomyocyte proliferation depending on the timescale of inhibition.
Two groups have recently highlighted the importance of nerves in neonatal mouse heart regeneration. 53, 54 Mahmoud et al demonstrated the importance of parasympathetic nerves in the regulation of cardiomyocyte proliferation and regeneration in both zebrafish and neonatal mice. Chemical sympathectomy was performed by injecting neonatal mice with 6-hydroxydopamine hydrobromide (6-OHDA), a neurotoxin that induces apoptosis in catecholaminergic neurons, which inhibited cardiac regeneration and promoted fibrosis. While robust denervation was observed in the heart, it is possible that the non-specificity of 6-OHDA treatment could induce apoptosis of other catecholaminergic terminals, such as in the central nervous system, that could affect heart regeneration. Therefore, from this data alone, it is difficult to assess the importance of sympathetic nerves in the context of cardiac regeneration.
The physiological events triggering cardiomyocyte cell-cycle arrest and loss of regenerative potential in mammals has remained enigmatic. In this study, we report that sympathetic nerve activity through βARs is one the triggers promoting cardiomyocyte cell-cycle exit and loss of proliferative capacity. While we observe increased cardiomyocyte mononucleation and proliferation in animals with perturbed βAR signaling, we also notice that the majority of cardiomyocytes (~80%) still underwent binucleation by P14. This implies that factors other than the sympathetic nervous system must also act to promote cardiomyocyte cellcycle arrest. Identification of these new signals will be important as it is likely that modulation of multiple pathways in combination will be necessary to unlock regenerative potential in adult mammals, which will provide us with new therapeutic strategies in regenerative medicine. , not significant. *, P-value < 0.05. **, P-value < 0.01, ***, P-value < 0.001, **** P-value < 0.0001. Scale bar represents 100 µm. 
